Kanvas Biosciences, Inc. — Form D
Kanvas Biosciences, Inc. of MONMOUTH JUNCTION, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-18. The offering totals $10.0M, of which $3.9M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-03-18
- Form: D
- Accession: 0001980849-24-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $3.9M
- Remaining: $6.1M
- Investors: 54
- Date of first sale: 2024-03-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-507864
Issuer
- Name: Kanvas Biosciences, Inc.
- CIK: 0001980849
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1 DEER PARK DRIVE, MONMOUTH JUNCTION, NJ, 08852
- Phone: 617-435-4900
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Matthew Cheng | Director | Monmouth Junction, NJ |
| Jason Pontin | Director | New York, NY |
| Hao Shi | Director | Monmouth Junction, NJ |
| Paul Theunissen | Director | Monmouth Junction, NJ |
| Matthew Cheng | Executive Officer | Monmouth Junction, NJ |
| Hao Shi | Executive Officer | Monmouth Junction, NJ |
| Justin Smithline | Director | Chadds Ford, PA |
| Iwijn De Vlaminck | Director | Monmouth Junction, NJ |
| Iwijn De Vlaminck | Executive Officer | Monmouth Junction, NJ |
Other filings by this issuer (1)
More